4.5 Article

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

Related references

Note: Only part of the references are listed.
Article Immunology

Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity

Kara L. Lynch et al.

Summary: Understanding the kinetics and magnitude of the host antibody response to SARS-CoV-2 is essential for understanding the pathogenesis of COVID-19 and identifying potential therapeutic targets. Research showed that IgM and IgG responses were significantly higher in patients with severe disease compared to those with mild disease, which may have implications for seroprevalence studies, therapeutics, and vaccine development strategies.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

COVID-19 Susceptibility and Outcomes Among People Living With HIV in San Francisco

Darpun Sachdev et al.

Summary: In San Francisco, people living with HIV had a higher susceptibility to COVID-19 during the first 6 months of the pandemic, but clinical outcomes were similar to those without HIV. Homelessness and higher rates of congregate living situations likely contributed to this disparity, highlighting the need for special efforts to house marginalized individuals during the COVID-19 pandemic.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

Article Immunology

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2

Ludivine Grzelak et al.

Summary: In a study of 308 healthcare workers with mild COVID-19, it was found that individuals over 50 years old and with a BMI over 25 kg/m(2) had higher levels of anti-S and anti-N antibodies in the first month. Between months 3-6, 99% of individuals had detectable anti-S antibodies, while 59% had anti-N antibodies. Additionally, anti-S and neutralizing antibodies declined faster in men compared to women, regardless of age and BMI.

JOURNAL OF INFECTIOUS DISEASES (2021)

News Item Multidisciplinary Sciences

NOVAVAX OFFERS FIRST EVIDENCE THAT COVID VACCINES PROTECT PEOPLE AGAINST VARIANTS

Ewen Callaway et al.

NATURE (2021)

Article Medicine, General & Internal

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

James M. Tesoriero et al.

Summary: This cohort study conducted in New York State found that persons living with diagnosed HIV had poorer outcomes related to COVID-19 compared to persons living without diagnosed HIV. Previous HIV diagnosis was associated with higher rates of severe disease requiring hospitalization, and hospitalization risk increased with progression of HIV disease stage.

JAMA NETWORK OPEN (2021)

Review Immunology

The interplay between HIV and COVID-19: summary of the data and responses to date

Lillian B. Brown et al.

Summary: Current evidence does not suggest that people living with HIV are at significantly higher risk of contracting SARS-CoV-2, but the prevalence of comorbidities associated with COVID-19 severity among PLWH remains a pressing issue. The COVID-19 epidemic has led to decreased access to HIV prevention services and testing, as well as worsened HIV treatment access and virologic control, potentially exacerbating the HIV epidemic.

CURRENT OPINION IN HIV AND AIDS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Sana Salehi et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2020)

Article Medicine, General & Internal

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study

Julia del Amo et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Immunology

COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States

Raul Macias Gil et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Hematology

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV

Chiara Papalini et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)

Letter Biochemistry & Molecular Biology

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Li Tan et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Medicine, Research & Experimental

Altered immune cell follicular dynamics in HIV infection following influenza vaccination

Eirini Moysi et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Infectious Diseases

CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients

Vivian I. Avelino-Silva et al.

PLOS NEGLECTED TROPICAL DISEASES (2016)

Article Veterinary Sciences

Confidence limits for prevalence of disease adjusted for estimated sensitivity and specificity

Zsolt Lang et al.

PREVENTIVE VETERINARY MEDICINE (2014)